Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 134241,
    "name": "Jagsonpal Pharma",
    "stock_name": "Jagsonpal Pharma",
    "full_name": "Jagsonpal Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jagsonpal-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "242.62",
    "chg": -1.35,
    "chgp": "-0.55%",
    "dir": -1,
    "prev_price": "243.97",
    "mcapval": "1,600.26 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507789,
    "symbol": "JAGSNPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE048B01035",
    "curr_date": "Sep 25, 10:01 AM",
    "curr_time": "10:19 AM",
    "last_traded_at": "Sep 25, 10:01 AM IST",
    "bse_nse_vol": "3.56 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4204060",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JagsonpalPharma_technicaldot_4204060.png",
        "date": "2026-09-25 08:00:19",
        "description": "Jagsonpal Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, with technical indicators signalling a bullish trend reversal. The stock’s recent 7.95% daily gain and upgrades in technical grades reflect growing investor confidence amid a broader market environment that remains challenging."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4201262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JagsonpalPharma_mojoScore_4201262.png",
        "date": "2026-09-22 10:10:03",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 September 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4190529",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JagsonpalPharma_mojoScore_4190529.png",
        "date": "2026-09-11 10:10:05",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4185436",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JagsonpalPharma_technicaldot_4185436.png",
        "date": "2026-09-08 08:00:27",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early September 2026. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to support a cautiously optimistic outlook, while other metrics suggest a more tempered trend. This article analyses the recent technical developments and their implications for investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4176122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_mojoScore_4176122.png",
        "date": "2026-08-31 10:10:04",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4162621",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_mojoScore_4162621.png",
        "date": "2026-08-20 10:10:05",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4144121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_mojoScore_4144121.png",
        "date": "2026-08-09 10:10:04",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4132772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_technicaldot_4132772.png",
        "date": "2026-08-03 08:00:17",
        "description": "Jagsonpal Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a more confident bullish trend. Despite a recent day decline of 2.68%, the stock’s underlying technical parameters suggest improving momentum that could influence investor sentiment in the coming weeks."
      },
      {
        "title": "Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jagsonpal-pharmaceuticals-ltd-latest-results-good-or-bad-4129032",
        "imagepath": "",
        "date": "2026-07-30 19:18:55",
        "description": "Jagsonpal Pharmaceuticals Ltd has reported its financial results for Q1 FY27, showcasing notable operational trends. The company achieved a record quarterly revenue of ₹82.23 crores, reflecting a sequential growth of 28.08% compared to the previous quarter. Year-on-year revenue growth was recorded at 8.76%, indicating steady market expansion despite competitive pressures.\n\nNet profit for the quarter stood at ₹13.19 crores, which represents a significant quarter-on-quarter increase of 50.56% and a year-on-year growth of 22.13%. The improvement in profitability is further underscored by an operating margin that expanded to 20.97%, up from 17.38% in the previous quarter, highlighting effective cost management and a favorable product mix.\n\nThe company's return on equity (ROE) is reported at 17.66%, which is above its five-year average, suggesting effective management in generating returns for shareholders. Addi..."
      }
    ],
    "total": 284,
    "sid": "134241",
    "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241"
  },
  "announcements": [
    {
      "details": "Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr ASHOK KUMAR PATI as Additional Non-Executive Independent Director of the company w.e.f. November 14, 2019.",
      "source": "NSE",
      "caption": "Jagsonpal Pharmaceuticals Limited - Appointment",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Jagsonpal Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Jagsonpal Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "19-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>200%</strong> dividend, ex-date: 04 Sep 26",
          "dt": "2026-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jagsonpal Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals

2026-09-25 08:00:19

Jagsonpal Pharmaceuticals Ltd has demonstrated a significant shift in price momentum, with technical indicators signalling a bullish trend reversal. The stock’s recent 7.95% daily gain and upgrades in technical grades reflect growing investor confidence amid a broader market environment that remains challenging.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-09-22 10:10:03

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 September 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-09-11 10:10:05

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-08 08:00:27

Jagsonpal Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early September 2026. Despite a slight dip in daily price, key indicators such as MACD and moving averages continue to support a cautiously optimistic outlook, while other metrics suggest a more tempered trend. This article analyses the recent technical developments and their implications for investors in the pharmaceuticals and biotechnology sector.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-08-31 10:10:04

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-08-20 10:10:05

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-08-09 10:10:04

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-03 08:00:17

Jagsonpal Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a more confident bullish trend. Despite a recent day decline of 2.68%, the stock’s underlying technical parameters suggest improving momentum that could influence investor sentiment in the coming weeks.

Read full news article

Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?

2026-07-30 19:18:55

Jagsonpal Pharmaceuticals Ltd has reported its financial results for Q1 FY27, showcasing notable operational trends. The company achieved a record quarterly revenue of ₹82.23 crores, reflecting a sequential growth of 28.08% compared to the previous quarter. Year-on-year revenue growth was recorded at 8.76%, indicating steady market expansion despite competitive pressures. Net profit for the quarter stood at ₹13.19 crores, which represents a significant quarter-on-quarter increase of 50.56% and a year-on-year growth of 22.13%. The improvement in profitability is further underscored by an operating margin that expanded to 20.97%, up from 17.38% in the previous quarter, highlighting effective cost management and a favorable product mix. The company's return on equity (ROE) is reported at 17.66%, which is above its five-year average, suggesting effective management in generating returns for shareholders. Addi...

Read full news article

View All News